Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 35Myelodysplastic Syndromes 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Hematologic Neoplasms 14Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Lymphoma, Non-Hodgkin 12Myeloproliferative Disorders 11Lymphoma 11Leukemia, Myelomonocytic, Chronic 11Graft vs Host Disease 10Primary Myelofibrosis 9Leukemia 9Hodgkin Disease 9Leukemia, Lymphocytic, Chronic, B-Cell 7Anemia, Refractory, with Excess of Blasts 7Multiple Myeloma 6Leukemia, Biphenotypic, Acute 6Burkitt Lymphoma 5Polycythemia Vera 4Lymphoma, Follicular 4Leukemia, Myeloid 4Leukemia, Lymphoid 4Anemia, Aplastic 4Thrombocythemia, Essential 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precancerous Conditions 3Neoplasms, Plasma Cell 3Neoplasms 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoproliferative Disorders 3

Interventions

Cytarabine 4Azacitidine 4venetoclax 3Whole-Body Irradiation 3Peripheral Blood Stem Cell Transplantation 3Injections 3Biopsy 3pegylated granulocyte colony-stimulating factor 2Tacrolimus 2Mitoxantrone 2Gemtuzumab 2Decitabine 2Daunorubicin 2Cyclophosphamide 2Cladribine 2Busulfan 2Bone Marrow Transplantation 2ruxolitinib 1fludarabine phosphate 1fludarabine 1fedratinib 1enasidenib 1aldesleukin 1Thiotepa 1Spinal Puncture 1Specimen Handling 1Social Determinants of Health 1Sirolimus 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Mycophenolic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Monocytic, Acute × Tacrolimus × 1 year × Clear all
NCT03670966 2026-05-04

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
30 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03970096 2026-03-12

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Fred Hutchinson Cancer Center

Phase 2 Recruiting
120 enrolled
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡